What is the role of PEG (Polyethylene Glycol) therapy, specifically Pegfilgrastim (Filgrastim), in managing neutropenia in patients undergoing chemotherapy or with a history of immunodeficiency?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board

Educational purpose only • Exercise caution as content is pending human review

Article Review Status

Submitted

Under Review

Approved

Last updated: January 23, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Related Questions

What are the side effects of Gadofluorine (Grafil) on cerebrospinal fluid (CSF)?

Can pegfilgrastim (pegylated filgrastim) be administered once every two weeks as primary prophylaxis against febrile neutropenia in patients undergoing chemotherapy?

What is the recommended use of Filgrastim (G-CSF) in patients with chemotherapy-induced neutropenia?

What does a left shift indicate in patients receiving Filgrastim (Granulocyte-Colony Stimulating Factor, G-CSF)?

When should a Complete Blood Count (CBC) be checked in a patient undergoing chemotherapy with capecitabine and oxaliplatin, and receiving filgrastim (Granulocyte-Colony Stimulating Factor (G-CSF)) to prevent neutropenia?

When to stop intravenous (IV) albumin after abdominal paracentesis in a patient with cirrhosis and significant ascites?

What is the recommended administration method, dosage, and duration for isotretinoin (Vastionin) in treating severe acne, and is 20mg three times a week sufficient?

What are the treatment options for a patient with a headache who cannot take Tylenol (acetaminophen) and has already taken a nonsteroidal anti-inflammatory drug (NSAID)?

Does a patient with a suspected ovarian cyst require hormonal evaluation and treatment?

What is the best approach for potassium supplementation and monitoring in a patient with hypokalemia prescribed Kdur (potassium chloride) 1.5 gm milliequivalent, considering potential impaired renal function and risk of hyperkalemia?

Is it okay to use Farxiga (dapagliflozin), metformin, and sitagliptin in a patient with type 2 diabetes and impaired renal function?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.